Seems the rumors from last week were well founded. IBM released the following press release: Strengthens IBM’s Ability to Help Healthcare and Government Sectors Use Information to Improve Public Health and Services. So another MDM vendors get’s acquired. There are only a few smaller MDM of Customer and MDM of Product data, and generalists, left. Seems the chips have fallen, and most big bets are made. But who has the vision, the money and now the assets, to dominate the still fast evolving MDM market? War has been elevated from a number of small, underdeveloped states, to large scale, first world nations. Should be fun to watch. Any volunteers to reconcile MDM product strategy at IBM?
On the vendor call with Arvind Krishna, GM, IBM Information Management and Bill Conroy, CEO and President, Initiate. I am thinking that these guys won’t even mention MDM. The new name is “data integrity solutions”. I wonder why IBM would want to downplay an MDM connection. Is it because it would create the obvious statement of MDM product strategy complexity at IBM? Anyway, 10 minutes in and MDM was mentioned once, almost in passing…
OK MDM was mentioned a second time – in first 12 minutes. Bottom line – good buy, by IBM, but which product line will this acquisition roll up into????
18 minutes in and the argument is that Initiate is very much a business application solution – the example shared focusing on the single view of patient across healthcare network with business oriented analytics. This explains nicely how CDI products continue to evolve from “integration” plays (when CDI was very much message/transaction based) to a place that is where the PIM vendors were (more business app, and lacking transaction/message support). Good example of more “convergence” in the MDM space… But still, only 2 mentions of MDM…
First question from the floor – how does this play in IBM MDM strategy? IBM’s response – signals a shift to more verticalization of MDM. This is obvious (it has been one of the five vectors of MDM complexity for several years), but why didn’t IBM lead off with this view/strategy?
Bottom line – seems like IBM is NOT positioning the acquisition as a boost to their MDM strategy; it seems MDM is just one “use case” for the Initiate asset. Good for healthcare users; troubling for IBM MDM product strategy.
Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.